Gurpreet Sodhi, MD
Advanced Heart Failure and Transplant Cardiology · Sacramento, CANPI 1225264617
Payments from drug & device makers
Across 537 payments — averaging $563.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$54K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$48K
- Boehringer Ingelheim$46K
- Pfizer$43K
- Actelion Pharmaceuticals US, Inc.$35K
- Abiomed$29K
- plus $47K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 17 | $53,837 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 94 | $48,298 |
| Boehringer Ingelheim | 58 | $46,208 |
| Pfizer | 41 | $43,133 |
| Actelion Pharmaceuticals US, Inc. | 52 | $35,395 |
| Abiomed | 109 | $28,723 |
| Lilly USA, LLC | 20 | $18,525 |
| Boehringer Ingelheim International GmbH | 2 | $10,100 |
| AstraZeneca | 20 | $7,576 |
| Abbott | 67 | $4,160 |
| Alnylam Pharmaceuticals Inc. | 6 | $2,922 |
| Akcea Therapeutics, Inc. | 3 | $771 |
| Novartis | 13 | $694 |
| Atricure, Inc. | 5 | $366 |
| Edwards Lifesciences | 3 | $304 |
| Merck | 4 | $268 |
| Medtronic | 2 | $222 |
| Vifor Pharma, Inc. | 5 | $208 |
| Merit Medical Systems Inc | 1 | $192 |
| E.r. Squibb & Sons, L.L.C. | 2 | $171 |
| Heartflow, Inc. | 1 | $145 |
| Impulse Dynamics (USA) Inc. | 1 | $137 |
| Chiesi USA, Inc. | 1 | $125 |
| Kestra Medical Technology Services, Inc. | 1 | $106 |
| Inari Medical, Inc. | 1 | $59 |
| Amgen | 2 | $52 |
| Johnson & Johnson | 3 | $38 |
| Itamar Medical Inc | 1 | $23 |
| United Therapeutics Corporation | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
How this compares
$302,783 in reported general payments places this provider in the 75th percentile of 111 advanced heart failure and transplant cardiology providers in California.
See all advanced heart failure and transplant cardiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Sacramento
- Munir JanmohamedSacramento$443K
- John ChinSacramento$205K
- Zi Jian XuSacramento$144K
- Nancy LuoSacramento$118K
- Imo EbongSacramento$65K
- Ronald WittelesStanford$4.1M
- James Heywoodla Jolla$2.1M
- Eldrin LewisStanford$1.8M
- Richard WrightSanta Monica$1.7M
- Eric AdlerSan Diego$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.